Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Canaquest Medical Corp
(OP:
CANQF
)
0.0140
UNCHANGED
Last Price
Updated: 3:43 PM EDT, Aug 12, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Canaquest Medical Corp
NHL Alumni Association partners with CanaQuest and NEEKA Health to Conduct Studies for Anxiety and Quality of Life in former NHL Players
October 31, 2023
Via
ACCESSWIRE
CANAQUEST Announces Award of European Cannabinoid Patent
September 19, 2023
Via
ACCESSWIRE
CanaQuest Awarded Best Global Medical Cannabinoid Development Company 2023 by UK-based Global Health & Pharma for their 8th Annual Healthcare and Pharmaceutical Program
July 26, 2023
Via
ACCESSWIRE
CanaQuest and Neeka Health Sign Agreement to Conduct Clinical Studies with Mentanine(R)
April 25, 2023
Via
ACCESSWIRE
CanaQuest Achieves Statistically Significant Results in Reduction of Seizures for Epilepsy Compared to Standard CBD
December 12, 2022
CanaQuest Achieves Statistically Significant Results in Reduction of Seizures for Epilepsy Compared to Standard CBD Drug Candidate, CQ-001 (cannabidiol "CBD" + IP formula), also demonstrated...
Via
iCrowdNewswire
CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD
December 08, 2022
Via
ACCESSWIRE
Canaquest Launches Mentanine (R) (Cannabidiol + IP Formula) in the US via WWW.CANAQUESTSTORE.COM, Supported by Western University Pre-Clinical Trials Targeting Anxiety, Depression and PTSD
September 08, 2022
Via
ACCESSWIRE
CanaQuest Files International Mentanine(R) Patent, a Scientific CBD Formulation for Mental Health
April 29, 2021
TORONTO, ON / ACCESSWIRE / April 29, 2021 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the "Company" or "CanaQuest"), an award-winning Life Science/Pharmaceutical company developing formulations...
From
CanaQuest Medical Corp.
Via
AccessWire
Topics
Cannabis
Intellectual Property
CanaQuest Medical Corp Appoints Investor Relations and PR Veteran Rob Rinderman as its New Director of Communications
April 07, 2021
TORONTO, ON / ACCESSWIRE / April 7, 2021 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the "Company" or "CanaQuest"), an award-winning Life Science/Pharmaceutical company developing health and wellness...
From
CanaQuest Medical Corp.
Via
AccessWire
Topics
Cannabis
Initial Public Offering
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
Starting at $3.75
/
week.
Subscribe Today